Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183,329 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low-dose hypomethylating agent decitabine in combination with aclacinomycin and cytarabine achieves a better outcome than standard FLAG chemotherapy in refractory/relapsed acute myeloid leukemia patients with poor-risk cytogenetics and mutations.
Li L, Zhang X, Yu H, Zhang M, Xu M, Liu J, Fu Y, Meng H, Lyu C, Li X, Zhou J. Li L, et al. Among authors: zhang m, zhang x. Onco Targets Ther. 2018 Oct 12;11:6863-6870. doi: 10.2147/OTT.S161919. eCollection 2018. Onco Targets Ther. 2018. PMID: 30349319 Free PMC article.
Treatment response, survival, safety, and predictive factors to chimeric antigen receptor T cell therapy in Chinese relapsed or refractory B cell acute lymphoblast leukemia patients.
Li L, Liu J, Xu M, Yu H, Lv C, Cao F, Wang Z, Fu Y, Zhang M, Meng H, Zhang X, Kang L, Zhang Z, Li J, Feng J, Lian X, Yu L, Zhou J. Li L, et al. Among authors: zhang m, zhang z, zhang x. Cell Death Dis. 2020 Mar 30;11(3):207. doi: 10.1038/s41419-020-2388-1. Cell Death Dis. 2020. PMID: 32231200 Free PMC article.
CD19 chimeric antigen receptor-T cells as bridging therapy to allogeneic hematopoietic cell transplantation improves outcome in patients with refractory/relapsed B-cell acute lymphoblastic leukemia.
Liu J, Xu M, Zhang X, Zhang Z, Zhong T, Yu H, Fu Y, Meng H, Feng J, Zou X, Han X, Kang L, Yu L, Li L. Liu J, et al. Among authors: zhang z, zhang x. Heliyon. 2024 Jul 1;10(13):e33937. doi: 10.1016/j.heliyon.2024.e33937. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39055833 Free PMC article.
183,329 results
You have reached the last available page of results. Please see the User Guide for more information.